[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1499 Engrossed in House (EH)]
H. Res. 1499
In the House of Representatives, U. S.,
July 28, 2010.
Whereas Dr. Robert M. Campbell, Jr., is a pediatric orthopedic surgeon
affiliated for many years with the University of Texas Health Science
Center at San Antonio and now Director of the Thoracic Insufficiency
Center at The Children's Hospital of Philadelphia;
Whereas Dr. Campbell has devoted his career to working with children suffering
from congenital scoliosis, fused ribs, small chest, and missing ribs;
Whereas Dr. Campbell, working with other specialists, helped identify Thoracic
Insufficiency Syndrome, which is associated with the rare conditions of
congenital scoliosis, fused ribs, small chests, and missing ribs, and
results in the inability of the thorax to support normal respiration or
lung growth which is often fatal in children;
Whereas the life-saving medical devices often used in adult care of rib
conditions are not designed or sized for the bodies of children
suffering from Thoracic Insufficiency Syndrome or similar conditions;
Whereas, over the years, physicians have often turned to adult devices, less
effective treatments, more invasive therapies, or jury-rigging makeshift
equipment to provide vital care for children;
Whereas doctors were often left with no effective treatment for these critically
ill children;
Whereas, in 1987, Dr. Robert Campbell, working together with the late Dr. Melvin
Smith, a professor of pediatric general surgery at CHRISTUS Santa Rosa
Children's Hospital, invented the Vertical Expandable Prosthetic
Titanium Rib, which is easy to implant and easy to expand with minor
outpatient surgery as the child grows;
Whereas the first successful surgery by Drs. Campbell and Smith in 1989 began a
long crusade to receive approval for the device from the Food and Drug
Administration (FDA); however, so few children are in need of such
devices that study trials stretched out for well over a decade;
Whereas, after over 14 years of advocacy by Dr. Campbell and Dr. Smith and in
large part due to their persistence and devotion to children, on
September 2, 2004, the Food and Drug Administration approved the
Vertical Expandable Prosthetic Titanium Rib;
Whereas the FDA found that the device was safe and of benefit in enabling
unassisted breathing and less dependence on ventilators, and that
without treatment, children with the syndrome risk death from
respiratory infections or inability to breathe;
Whereas, since the FDA approval, the Vertical Expandable Prosthetic Titanium Rib
for children with conditions such as Thoracic Insufficiency Syndrome,
Jeune syndrome, and other medical problems that constrict the growth of
children's lungs has saved the lives of hundreds of children with no
other hope for survival;
Whereas the National Organization for Rare Disorders (NORD) and the Office of
Orphan Products Development at the FDA made critical investments in Dr.
Campbell's technology;
Whereas Dr. Campbell has served as an advocate for children with rare medical
conditions across the Nation by providing many hours of volunteer
service to the National Organization for Rare Disorders (NORD) as a
member of its Medical Advisory Committee; and
Whereas Dr. Campbell has also served as an advocate for children through actions
such as his March 27, 2007, testimony before the United States Senate
Committee on Health, Education, Labor, and Pensions entitled ``Ensuring
Safe Medicines and Medical Devices for Children'': Now, therefore, be it
Resolved, That the House of Representatives--
(1) honors Dr. Robert Campbell for his lifelong devotion to
children's health care;
(2) congratulates Dr. Robert Campbell and his colleagues on their
extraordinary achievement in pediatric and orthopedic innovation; and
(3) recognizes the Vertical Expandable Prosthetic Titanium Rib
device which has saved the lives of so many infants and children, while
giving hope to their families.
Attest:
Clerk.